Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

In obese patients without gallstones, a 6-month treatment course of ursodeoxycholic acid (UDCA) following bariatric surgery may reduce their likelihood of developing symptomatic gallstones, according to findings of the UPGRADE trial from The Netherlands presented at DDW 2021.

Audrey Abella, 31 May 2021
Apart from reducing bleeding risk in individuals with advanced oesophageal cancer (ESCA) who had self-expanding metal stent (SEMS) insertion to improve dysphagia, concurrent palliative radiotherapy (RT) does not reduce recurrent dysphagia nor does it improve overall survival (OS), findings from the phase III ROCS* study have shown.